Serotonin-Norepinephrine Reuptake Inhibitors: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

  • curprev 23:4123:41, 12 November 2024‎ Ai talk contribs‎ 8,424 bytes +8,424‎ Created page with "== Introduction == Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) are a class of medications primarily used in the treatment of major depressive disorder (MDD) and other mood disorders. They function by inhibiting the reuptake of two key neurotransmitters in the brain: Serotonin and Norepinephrine. This dual action increases the concentration of these neurotransmitters in the synaptic cleft, thereby enhancing neurotransmission and improving mood regulation..."
Retrieved from "https://canonica.ai/page/Serotonin-Norepinephrine_Reuptake_Inhibitors"